Related Experiment Video
Updated: Jun 2, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Circulating levels of growth differentiation factor-15 and its genetic variants -3148C>G (rs4808793) in pediatric
Eman Ahmed Abd-Elmawgood1, Mohammed H Hassan2,3, Khaled Abdalla Abd-Elbaseer1
1Department of Pediatrics, Faculty of Medicine, Qena University, Qena 83523, Egypt.
Background:
Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine. Though less extensively studied in children than in adults, recent evidence highlights the potential value of GDF-15 in pediatric cardiology.
Aim:
To assess the serum GDF-15 levels and the genetic profile of GDF-15 rs4808793 among children with cardiac diseases.
Methods:
This case-control study included 100 pediatric cardiac patients and 50 healthy controls. GDF-15 rs4808793 (-3148C>G) single-nucleotide polymorphism was tested via restriction fragment length polymorphism-polymerase chain reaction technique, and serum GDF-15 was measured using the enzyme-linked immunosorbent assay technique.
Results:
Of the 69 children with various types of congenital heart diseases (CHD), 14 patients had rheumatic heart disease, and 17 had cardiomyopathy. About 50% of patients had heart failure. Significantly higher mean serum GDF-15 among patients compared to the controls, P < 0.001. Heart failure patients had significantly higher serum GDF-15 than those who didn't, P < 0.001. CC-genotype and C-allele of rs4808793 were significantly more frequent among cardiac patients compared to the controls (P = 0.002). C-allele of rs4808793 was associated with an increased CHD risk (odds ratio = 2.812, 95% confidence interval: 1.648-4.799).
Conclusion:
GDF-15 is a promising biomarker in predicting congenital heart disease and heart failure in children. The genetic variants of GDF-15 (rs4808793) were significantly associated with CHD risk.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

